The Board has considered and approved the unaudited Financial Results (Standalone and Consolidated) for the 3rd quarter and nine months ended December 31 2025 including reappointment of CEO & MD.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]